QUEBTI
Live / Applied — Suspended — suspension letter mailed (as of 23 Mar 2026)
What this means for you
Not registered yet, but its 05 Dec 2025 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99531504
- Mark type
- Stylized text
- Filed
- 05 Dec 2025
- Attorney of record
- Elizabeth K. Rucki
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of damaged skin and tissue, pain, inflammation, obesity, and infectious diseases; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, hematological, bacterial, respiratory, neurological, gastrointestinal, dermatological, psychiatric, and immune system related diseases and disorders; Pharmaceutical preparations for the prevention of infectious diseases; Vaccines; Anti-infectives
Owner
- Glaxo Group Limited, Stevenage, GB
Prosecution history
- 02 Apr 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 02 Apr 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 02 Apr 2026 — TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
- 23 Mar 2026 — NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
- 23 Mar 2026 — LETTER OF SUSPENSION E-MAILED
- 23 Mar 2026 — SUSPENSION LETTER WRITTEN
- 20 Mar 2026 — ASSIGNED TO EXAMINER
- 05 Dec 2025 — APPLICATION FILING RECEIPT MAILED
- 05 Dec 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 05 Dec 2025 — NEW APPLICATION ENTERED